<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> Dec-31-1996 <PERIOD-END> Mar-31-1996<F1> <CASH> 1305 <SECURITIES> 501 <RECEIVABLES> 2386<F2> <ALLOWANCES> 0 <INVENTORY> 1484 <CURRENT-ASSETS> 6762 <PP&E> 6341 <DEPRECIATION> 2576 <TOTAL-ASSETS> 13824 <CURRENT-LIABILITIES> 4760 <BONDS> 626 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 54 <OTHER-SE> 5882 <TOTAL-LIABILITY-AND-EQUITY> 13824 <SALES> 3,669 <TOTAL-REVENUES> 3,669 <CGS> 935 <TOTAL-COSTS> 935 <OTHER-EXPENSES> 729 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 24 <INCOME-PRETAX> 1,022 <INCOME-TAX> 296 <INCOME-CONTINUING> 726 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 726 <EPS-PRIMARY> 1.44 <EPS-DILUTED> 0 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.